🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsCardiovascular OutcomesBlood pressure reduction mechanisms on GLP-1 — natriuresis Page 3

Blood pressure reduction mechanisms on GLP-1 — natriuresis

Dr.RenalNash Sat, Jun 6, 2026 at 6:10 PM 18 replies 335 viewsPage 3 of 4
SaraMom3
Member
456
2,345
Aug 2024
Ohio
Jun 7, 2026 at 4:13 AM#11
newstart_MO said:
The mechanism is more central than most summaries suggest.

That reframing is the part I needed. Sending this to two other people who asked me the same thing last week.

Last edited: Jun 7, 2026 at 8:13 AM
14 14BethLabQueen, ChrisMacros, KetoKyle and 11 others
Reply Quote Save Share Report
BariatricNurseD
Senior Member
1,678
7,234
Feb 2024
Dallas, TX
Online
Jun 7, 2026 at 8:36 AM#12

Adding the clinical framing, because it changes how the question reads.

Dizziness and cardiovascular risk: I was lightheaded for the first 3 weeks. Root cause was a combination of reduced caloric intake and mild dehydration.

Fix: minimum 80-100oz water daily, don't skip meals even if you're not hungry (eat small protein-rich snacks), and stand up slowly from sitting/lying positions. Also check your blood pressure — GLP-1-induced weight loss can make BP meds too strong, requiring dose reduction.

13 13roxy_nash, tony_orlando, Dr.NephBHM_UK and 10 others
Reply Quote Save Share Report
DebRD_ATL
Senior Member
1,678
7,890
Feb 2024
Atlanta, GA
Jun 7, 2026 at 12:59 PM#13
DeniseRN_TPA said:
I want to bring up the cardiovascular angle on cardiovascular risk.

CRP reduction on cardiovascular risk — this is the lab result that excites me most:

Baseline hsCRP: 8.0 mg/L (high cardiovascular risk)
Month 6 hsCRP: 1.5 mg/L (moderate risk)
Month 12 hsCRP: 0.8 mg/L (low risk)

This level of inflammatory marker reduction is comparable to what you'd see with statin therapy. Combined with the weight loss, my 10-year ASCVD risk score dropped from 15% to 4%. My cardiologist is genuinely impressed.

Last edited: Jun 7, 2026 at 4:59 PM
12 12SleepDoc_PDX, RegAffairsDC, BiostatsBrad and 9 others
Reply Quote Save Share Report

Janoshik Analytical — Independent Testing

Trusted third-party HPLC & mass spectrometry analysis. Verify peptide purity with the lab the community relies on. Independent. Accurate. Transparent.

Verify Your Peptides

GL Biochem (Shanghai) Ltd. — Direct Manufacturer

Est. 1998. The synthesis house behind the vials you send for testing. ISO 9001 and cGMP certified, 1,500+ staff, batch-specific COA with every order.

Browse GL Biochem
dave_SLC
Member
345
1,567
Aug 2024
Salt Lake City, UT
Jun 7, 2026 at 5:22 PM#14
Dr.RenalNash said:
SELECT is the trial that changed the framing of this class, because it was an outcome trial rather than a weight trial: about a 20% relative reduction…

Cardiac biomarkers and cardiovascular risk: my cardiologist ordered advanced cardiac labs given my family history. Results were encouraging:

  • NT-proBNP: 52 pg/mL (normal, cardiac function preserved)
  • Lp(a): 32 nmol/L (genetic, unchanged — expected)
  • ApoB: dropped from 137 to 92 mg/dL (excellent response)
  • Coronary calcium score: 0 (unchanged from baseline — reassuring)

The ApoB reduction is particularly meaningful — it's considered the best single predictor of cardiovascular risk. GLP-1 therapy seems to improve this consistently.

11 11FranDenver, Dr.BariatricHTX, LindaRN_retired and 8 others
Reply Quote Save Share Report
Admin
Administrator
2,456
9,812
Oct 2023
Online
Jun 7, 2026 at 9:45 PM#15

Moderator note: the sourcing question belongs in the vendor section and has been split out. Tagging this one for the weekly digest.

Last edited: Jun 8, 2026 at 1:45 AM
10 10PeptideSynthNJ, Dr.KarenChen, Dr.NateNeph and 7 others
Reply Quote Save Share Report

Similar Threads

SELECT trial: 20% MACE reduction — mechanistic deep dive7 replies
Semaglutide cardiovascular benefit independent of weight loss11 replies
STEP-HFpEF: semaglutide in heart failure with preserved EF15 replies
GLP-1 and arterial inflammation — hsCRP and IL-6 reduction data18 replies
Lp(a) on GLP-1 agonists — any impact on this risk factor?8 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register